TARO - Taro Pharmaceutical Industries
Previous close
42.97
0 0%
Share volume: 14,845
Last Updated: Fri 21 Jun 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$42.97
0.00
0.00%
Fundamental analysis
39%
Profitability
36%
Dept financing
5%
Liquidity
75%
Performance
42%
Performance
5 Days
0.56%
1 Month
0.51%
3 Months
2.09%
6 Months
1.56%
1 Year
10.83%
2 Year
13.08%
Key data
Stock price
$42.97
DAY RANGE
$42.89 - $42.97
52 WEEK RANGE
$32.67 - $45.76
52 WEEK CHANGE
$0.11
DIVIDEND
$12.81
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Uday Baldota
Region: US
Website: http://www.taro.com
Employees: 1,339
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.taro.com
Employees: 1,339
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
established in 1950, taro pharmaceutical industries ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. taro’s research programs and niche strategy have enabled the company to achieve gross margins that are among the highest in the specialty pharmaceutical sector.
Recent news